Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
INTS
INTS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
INTS News
Intensity Therapeutics Regains Nasdaq Compliance
5d ago
seekingalpha
Intensity Therapeutics Regains Nasdaq Compliance
5d ago
PRnewswire
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
Feb 13 2026
Benzinga
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
Feb 13 2026
stocktwits
Intensity Therapeutics Announces Reverse Stock Split Plan
Feb 13 2026
PRnewswire
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
Feb 13 2026
Newsfilter
Intensity Therapeutics Inc. Board Greenlights 1-for-25 Reverse Stock Split
Feb 13 2026
moomoo
Intensity Therapeutics Highlights 2025 Milestones and 2026 Strategic Priorities
Jan 13 2026
PRnewswire
Everything You Should Know About the Rating Upgrade to Buy for Intensity Therapeutics Inc. (INTS)
Dec 15 2025
NASDAQ.COM
Intensity Therapeutics Receives 180-Day Nasdaq Compliance Extension
Dec 05 2025
Newsfilter
Intensity Therapeutics Secures 180-Day Nasdaq Compliance Extension
Dec 05 2025
PRnewswire
Intensity Therapeutics Granted 180-Day Extension by Nasdaq to Achieve Compliance
Dec 05 2025
SeekingAlpha
Dow Drops More Than 100 Points as Amazon Reports Positive Q3 Results
Oct 31 2025
Benzinga
Nasdaq Rises More Than 1%; Apple Reports Earnings Exceeding Expectations
Oct 31 2025
Benzinga
Intensity Therapeutics Shares Surge Nearly 400% Following Promising Solid Tumor Results
Oct 31 2025
Yahoo Finance
Intensity Therapeutics reveals pricing for $4M registered direct common stock offering
Oct 31 2025
SeekingAlpha
Show More News
